Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
BioConferenceLive

Advanced Incubation Solution Introduced for Cell-Based Research

By BiotechDaily International staff writers
Posted on 31 Jan 2013
Image: The Thermo Scientific Cytomat 10 automated incubator (Photo courtesy of Thermo Fisher).
Image: The Thermo Scientific Cytomat 10 automated incubator (Photo courtesy of Thermo Fisher).
An automated incubator and storage module provides superior cell growth and assay incubation and a reliable thermal decontamination routine.

Thermo Fisher Scientific (Waltham, MA, USA) has now introduced the new Thermo Scientific Cytomat 10, an automated incubator and storage module designed to provide superior environmental control for cell growth and assay incubations in laboratories performing high-throughput cell biology or screening. The Cytomat 10 provides a fast plate access time of less than 10 seconds. Additionally, multiple transfer positions and an under-bench version allow flexible incubator placement within the laboratory. As the first generation of automated incubator with a fully validated thermal decontamination system, the Thermo Scientific Cytomat 10 is designed to significantly decrease the risk of contamination and reduce assay variability.

Utilizing more than 40 years of experience in CO2 incubator technology, the Thermo Scientific Cytomat 10 design provides scientists with a reliable, robust incubation unit for precious cell cultures and assays. The design virtually eliminates recovery times with a heated automatic access door, with small opening. The efficient thermal disinfection method practically eliminates germs and spore suspensions, even in areas difficult to reach via manual cleaning. Based on the trusted ContraCon Routine of the Thermo Scientific HERAcell incubators, the Cytomat 10’s decontamination is carried out in wet conditions at 90 °C, leaving incubators virtually residue-free. The Thermo Scientific Cytomat 10 incorporates humidity control via an external water reservoir, reducing the risk of contamination from an internal source and the need for repetitive incubator access.

As a flexible incubation unit, the Cytomat 10 incorporates the Thermo Scientific internally automated PSS (Plate Shuttle System) to serve multiple access and loading positions. Cytomat 10 includes an LCD monitor for incubation parameters and full text read-out messaging to inform the user of temperature, humidity, and gaseous atmosphere level changes. The unit can also be seamlessly integrated with existing automated assay hardware.

Related Links:

Thermo Fisher Scientific, Inc.
Thermo Scientific Cytomat 10





comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.